Clinical trials
Bronchiectasis clinical trials
Below are recruiting bronchiectasis clinical trials, each written for real people, not researchers. We’re tracking 82 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06931002Recruiting
Cold virus study in bronchiectasis and healthy volunteers
This study tests whether giving a common cold virus (rhinovirus) to people with bronchiectasis and healthy volunteers can trigger a lung flare-up. It aims to understand how the immune system responds and what causes exacerbations, which could lead to better treatments.
LondonAges 18–65 - NCT07599839Recruiting
Study of bronchiectasis severity and flare-up risk
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
Asyut, Asyut EgyptAges 18 years+ - NCT07599969Recruiting
Understanding bronchiectasis subtypes for better treatment
This study helps doctors identify different types of bronchiectasis (a lung disease where airways are permanently widened and damaged) to better understand how the disease develops and progresses. By following patients over time and collecting medical information, researchers hope to create a system that predicts which patients will worsen and need different treatments.
Asyut, Assiut EgyptAges 18 years+ - NCT07283497RecruitingPhase 4
Itraconazole for bronchiectasis with airway mold growth
This Mayo Clinic study tests whether the oral antifungal drug itraconazole can help people with bronchiectasis who have mold growing in their airways. The goal is to see if it improves symptoms and reduces mold in the lungs.
Rochester, MinnesotaAges 18 years+ - NCT06872892RecruitingPhase 3
Study of BI 1291583 for people with bronchiectasis
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
Birmingham, AlabamaAges 12 years+ - NCT07774403RecruitingPhase 2
Study of AZD0292 in Chinese patients with bronchiectasis and chronic Pseudomonas infection
This study tests a new medication called AZD0292 for people with bronchiectasis who have a long-term Pseudomonas infection. It aims to see if the drug can reduce flare-ups and improve lung health.
AnyangAges 18 years+ - NCT07088926RecruitingPhase 2
Study of a new medicine for bronchiectasis with chronic Pseudomonas infection
This study tests a new medicine (AZD0292) given through a vein for people with bronchiectasis and a chronic Pseudomonas lung infection. It aims to see if it can reduce flare-ups and improve lung health.
Orange, CaliforniaAges 12 years+ - NCT07201051RecruitingPhase 2
Testing a new drug for people with bronchiectasis
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
Mobile, AlabamaAges 18–85 - NCT07566611Recruiting
Ciliary Function in Adults with Bronchiectasis
This study looks for signs of ciliary dyskinesia (a condition affecting tiny hair-like structures in the lungs) in adults who have bronchiectasis (damaged airways). Understanding this connection may help doctors better treat and manage your lung disease.
Indianapolis, IndianaAges 18 years+ - NCT07720375RecruitingPhase 2
Study of a new medication for adults with bronchiectasis
This study tests a new medication called Galvokimig to see if it helps reduce lung infections and improve quality of life in adults with bronchiectasis (a condition where lung airways are damaged and fill with mucus). It is a 24 to 52 week treatment, and you will be monitored closely for safety and effectiveness.
Plantation, FloridaAges 18–80 - NCT03791086Recruiting
BRIDGE study using health records and genetics for bronchiectasis
This study looks at how bronchiectasis (ongoing lung damage with mucus and infections) may happen by using your medical records and genetic information. It may help researchers find better ways to understand different bronchiectasis types and guide future treatments.
DundeeAges 18 years+ - NCT04538859Recruiting
Study of causes of flare-ups and death in bronchiectasis
This study looks at what factors are linked to flare-ups and serious outcomes in people with non–cystic fibrosis bronchiectasis. You may be followed because your lung scans and recent stability help researchers understand what predicts worsening.
Hong Kong, Please SelectAges 18 years+ - NCT01822834Recruiting
Registry for adults with bronchiectasis and non-tuberculosis lung bacteria
This study is a registry that collects health information from adults who have bronchiectasis caused by non-tuberculosis mycobacteria (NTM). It helps researchers better understand this condition and improve future treatments.
Washington D.C., District of ColumbiaAges 18–120 - NCT06660992RecruitingPhase 3
Study of HSK31858 for non-CF bronchiectasis
This trial tests a new medicine, HSK31858, for people with non-cystic fibrosis bronchiectasis (a lung condition causing chronic cough and infections). It aims to see if the drug reduces lung flare-ups and improves symptoms.
Guangzhou, GuangdongAges 18 years+ - NCT06487273Recruiting
SIMEOX device for mucus clearance at home in bronchiectasis
This study tests a home-use device called SIMEOX, which helps clear mucus from your lungs. It is for adults with bronchiectasis (not cystic fibrosis) who have frequent lung infections.
AbbevilleAges 18 years+ - NCT06987214RecruitingPhase 1
Regenerative stem cell therapy for bronchiectasis
This trial tests whether transplanting your own lung stem cells can repair damaged airways caused by bronchiectasis. It is for people with moderate to severe breathing impairment and aims to improve lung function.
Qionghai, HainanAges 25–80 - NCT07709494RecruitingPhase 1
Inhaled Rev-56 for healthy volunteers and people with bronchiectasis
This trial tests an inhaled drug called Rev-56 in healthy adults and in adults with non-cystic fibrosis bronchiectasis who have a chronic lung infection with Pseudomonas aeruginosa. It aims to see if the drug is safe, well-tolerated, and helps reduce the bacteria in the lungs.
Miami, FloridaAges 18–80 - NCT07048262RecruitingPhase 2
Study of an inhaled drug for adults with non-CF bronchiectasis
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
QueenslandAges 18–85 - NCT07135284Recruiting
Testing the LibAirty System for Bronchiectasis at Home
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
Birmingham, AlabamaAges 21 years+ - NCT06443658RecruitingPhase 3
The ELTGOL breathing technique: Clearing phlegm faster
This study tests whether inhaling a saltwater spray before a special breathing exercise (ELTGOL) helps people with bronchiectasis cough up phlegm more easily. It's for adults who have daily phlegm, recent flare-ups, and have not smoked much.
GironaAges 18 years+ - NCT06559150RecruitingPhase 2
Study of ensifentrine for non-cystic fibrosis bronchiectasis
This trial tests an inhaled drug called ensifentrine in people with bronchiectasis (damaged, widened airways in the lungs). The goal is to see if it can reduce flare-ups and improve symptoms.
Birmingham, AlabamaAges 18–80 - NCT07728006Enrolling by invitation
Bronchiectasis quality of life questionnaire study for children and teens
This study aims to create a quality of life questionnaire specifically for children and teenagers with bronchiectasis. You can help by sharing your experiences through questionnaires, which will help doctors better understand how bronchiectasis affects daily life.
BirminghamAges 2 years+ - NCT07616375RecruitingPhase 3
Safety Study of HSK31858 for Bronchiectasis
This study tests how safe an experimental inhaled medicine (HSK31858) is for people with non-cystic fibrosis bronchiectasis, a lung condition where airways are damaged and collect mucus. You can only join if you already completed a previous HSK31858 study.
Yixingcun, JiangxiAges 18 years+ - NCT07495982Recruiting
Inflammation markers and CT scans in stable bronchiectasis
This study looks at whether certain blood tests and CT scans can help predict when someone with bronchiectasis might have a flare-up (worsening of symptoms). It may help doctors better understand and manage the condition.
SohagAges 18 years+
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Bronchiectasis trials by city
Studies with a site in or near these metro areas.
Bronchiectasis trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for bronchiectasis?
- Yes. Clin2 currently lists 82 recruiting bronchiectasis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bronchiectasis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bronchiectasis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.